An ShRNA Based Genetic Screen Identified Sesn2 as a Potential Tumor Suppressor in Lung Cancer via Suppression of Akt-mTOR-p70S6K Signaling
Main Authors: | Xu, Hui, Sun, Huiying, Zhang, Haiyuan, Liu, Jiawei, Fan, Fangfang, Li, Yilan, Ning, Xuelian, Sun, Yue, Dai, Shaochun, Liu, Baogang, Gao, Min, Fu, Songbin, Zhou, Chunshui |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4427398/ |
Similar Items
-
Construction of shRNA lentiviral vector
by: Song, Hong, et al.
Published: (2010) -
Optimized PCR Conditions and Increased shRNA Fold Representation Improve Reproducibility of Pooled shRNA Screens
by: Strezoska, Žaklina, et al.
Published: (2012) -
Regulatory Effects of Sestrin 3 (SESN3) in BCR-ABL Expressing Cells
by: Vakana, Eliza, et al.
Published: (2013) -
Influence of ezrin-shRNA in combination with HSP70 on the apoptosis and proliferation of osteosarcoma cells
by: Yao, Qin, et al.
Published: (2016) -
Co-delivery of doxorubicin and recombinant plasmid pHSP70-Plk1-shRNA by bacterial magnetosomes for osteosarcoma therapy
by: Cheng, Li, et al.
Published: (2016)